Real-World eligibility for dapagliflozin in unselected heart failure patients: Data from the CORDIS-HF registry
This study aimed to investigate which proportion of patients with Heart Failure would be eligible for DAPA treatment in a real-world clinical practice.
This study aimed to investigate which proportion of patients with Heart Failure would be eligible for DAPA treatment in a real-world clinical practice.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
